Skip to content

endocrine-metabolic disease and sleep apnea syndrome study

endocrine-metabolic disease and sleep apnea syndrome study - Endocrine-Metabolic disease and Sleep apnea syndrome Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000002998
Enrollment
200
Registered
2010-08-09
Start date
2008-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endocrine-metabolic disease

Interventions

None listed

Sponsors

Osaka University
Lead Sponsor
TEIJIN PHARMA LIMITED
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects with endocrine-metabolic disease (diabetes, acromegaly and Cushing disase), and the study was approved by the human ethics committee of Osaka University and a written informed consent was obtained from eac subject.

Exclusion criteria

Exclusion criteria: Subjects under domiciliary oxygen therapy and/or nasal CPAP therapy

Design outcomes

Primary

MeasureTime frame
Evaluation of the prevarence and severity of sleep apnea syndrome in patients with endocrine-metabolic disease

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026